These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14109924)

  • 21. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protein extract of the prostate in the treatment of prostatic hypertrophy].
    BARTHELEMY H
    J Urol Nephrol (Paris); 1962; 68():814-6. PubMed ID: 13969684
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
    Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular steroids, prolactin, relaxin and prostate gland markers in peripheral blood and seminal plasma of normal dogs and dogs with prostatic hyperplasia.
    Wolf K; Kayacelebi H; Urhausen C; Piechotta M; Mischke R; Kramer S; Einspanier A; Oei CH; Günzel-Apel A
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():243-6. PubMed ID: 23279510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MEDICAL AND SURGICAL MANAGEMENT OF PROSTATIC DISEASE].
    ALVAREZIERENAJDE J; FLORES A; GARCIAIRIGOYEN C
    Rev Med Hosp Gen (Mex); 1963 Oct; 26():721-40. PubMed ID: 14096981
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intraprostatic injection of 96% ethanol in experimental animal model].
    Martov AG; Pavlov DA; Kirpatovskiĭ VI; Kudriavtsev IuV
    Urologiia; 2004; (6):21-6. PubMed ID: 15719725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the age for a preventive ultrasonographic examination of the prostate in the dog.
    Mantziaras G; Alonge S; Faustini M; Luvoni GC
    Theriogenology; 2017 Sep; 100():114-119. PubMed ID: 28708525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On drug therapy of prostatic hypertrophy].
    Rieben W
    Praxis; 1967 Jul; 56(30):1042-7. PubMed ID: 4180980
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
    Kobayashi S; Tomiyama Y; Tatemichi S; Hoyano Y; Kobayashi M; Yamazaki Y
    Eur J Pharmacol; 2009 Jun; 613(1-3):135-40. PubMed ID: 19389393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological study of prostate extracts. (IV). Prostatic acid phosphotases from several different species, and the effect of prostate extracts on these enzymes].
    Koda A; Hiramatsu M; Yoshida Y
    Nihon Yakurigaku Zasshi; 1974 Sep; 70(5):609-19. PubMed ID: 4141986
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
    Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
    Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of the effect of prostate extracts].
    Costa J; Guedes JM; Reis MO
    J Med (Oporto); 1965 Dec; 58(196):1024-7. PubMed ID: 4159123
    [No Abstract]   [Full Text] [Related]  

  • 36. The induction of prostatic hypertrophy in the dog with androstanediol.
    Walsh PC; Wilson JD
    J Clin Invest; 1976 Apr; 57(4):1093-7. PubMed ID: 59740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HISTOLOGICAL APPEARANCE OF THE PROSTATE OF NORMAL AND CASTRATED RATS TREATED BY A PROSTATIC EXTRACT].
    THIEBLOT L; BLAISE S
    Therapie; 1964; 19():857-60. PubMed ID: 14190940
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.
    Noa M; Arruzazabala ML; Carbajal D; Más R; Molina V
    Int J Tissue React; 2005; 27(4):203-11. PubMed ID: 16440586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-prostatic injection of botulinum toxin type A in treatment of dogs with spontaneous benign prostatic hyperplasia.
    Mostachio GQ; Apparício M; Motheo TF; Alves AE; Vicente WR
    Anim Reprod Sci; 2012 Aug; 133(3-4):224-8. PubMed ID: 22819377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution to therapy of the "prostate syndrome" in aged dogs].
    Bilkei G; Biro O; Takacs T; Kotai I; Szenci O; Goos T
    Berl Munch Tierarztl Wochenschr; 1997 Jun; 110(6):220-2. PubMed ID: 9290046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.